用于规划和执行人体经颅超声神经调控实验的管道
June 28th, 2024
2.6K views
经颅超声刺激 （TUS） 是一种新兴的非侵入性神经调控技术，需要仔细规划声学和热模拟。该方法描述了图像处理和超声模拟管道，用于高效、用户友好、简化的人体 TUS 实验规划。
我们的研究旨在了解经颅超声刺激对人类造成可测量影响的细节，包括参数规格及其调节深部大脑结构的能力。我们的方案简化了在人体中完成经颅超声刺激实验所需的计划步骤。它高效、易于使用，并且涉及使用开源可访问的规划工具。
我们最近的研究结果揭示了经颅超声刺激中最佳参数选择对实现神经元抑制的影响。这将有助于开发和设计未来的人类实验，为我们对这项技术的理解和进步做出重大贡献。
概述
本文介绍了一种经颅超声刺激（TUS）的协议，这是一种非侵入性的神经调控技术，旨在调节深部脑结构。该研究详细说明了使用开源工具规划人类TUS实验的高效工作流程，以便于该过程。
关键研究组成部分
科学领域
- 神经科学
- 神经调控
- 医学成像
背景
- 对TUS对人脑影响的理解仍在不断发展。
- 参数优化对于有效的神经调控至关重要。
- 很少有研究简化了TUS的实验规划。
- 开源工具为研究人员提供了可访问的平台。
研究目的
- 开发一种规划TUS实验的综合方法。
- 增进对TUS对神经元活动影响的理解。
- 便利使用TUS的未来实验设计。
使用的方法
- 该方法包括高分辨率MRI和将成像数据转换为兼容格式。
- 处理参与者的结构图像以实现准确的目标和轨迹映射。
- 使用定制软件模拟声学和热参数。
- 关键步骤包括为实验期间精确定位配置标志和轨迹。
- 实验期间固定参与者以最小化运动并确保准确性。
主要结果
- 该协议揭示了选择最佳参数对于实现神经元抑制的重要性。
- 研究强调准确的目标识别和模拟结果对于成功的TUS应用至关重要。
- 参与者展示了可靠的注册，确保了换能器的精确放置。
- 该方法为未来人类TUS干预研究提供了验证。
结论
- 本研究为人类TUS实验建立了一种简化的方法，增强了非侵入性神经调控研究。
- 通过使用开源工具，该协议使进一步研究脑刺激效应的进展变得可行。
- 研究结果支持了对TUS作为一种可行的神经调控技术的日益增长的兴趣，为创新的临床应用铺平了道路。
常见问题
使用开源工具规划TUS的优势是什么？
开源工具增强了可访问性，并允许研究人员定制工作流程，提高了规划TUS实验的整体效率。
在该方法中如何确定TUS的目标？
目标通过高分辨率MRI和仔细映射与特定脑区域相对应的标志来确定。
从TUS实验中获得哪些类型的数据？
数据包括空间注册准确性、神经元抑制测量，以及TUS应用过程中声学和热性能的模拟结果。
这种方法可以适应不同的患者群体吗？
是的，该协议可以根据不同患者群体的具体要求和解剖考虑进行修改，以实现个性化的TUS干预。
所描述的TUS协议的局限性是什么？
局限性可能包括对详细解剖知识的要求以及对设备进行精确校准以确保准确定位的需求。
Executive Industry Relevance
Transcranial ultrasound neuromodulation experiments in humans require rigorous planning to ensure precise targeting, safety, and reproducibility. This protocol integrates advanced imaging, simulation, and neuronavigation to de-risk early-stage neuromodulation research and enable reliable hypothesis testing. The workflow supports translational continuity from discovery through preclinical validation, positioning TUS as a scalable platform for central nervous system target interrogation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise mapping and modulation of deep brain structures for functional target validation.
- Supports mechanistic de-risking by integrating acoustic and thermal simulations to predict biological effects.
- Facilitates hypothesis-driven interrogation of neural circuits with quantitative imaging and simulation outputs.
Screening & Assay Development
- Standardizes preparation of individualized anatomical models for reproducible neuromodulation experiments.
- Delivers quantitative readouts for acoustic field and thermal safety, supporting assay reliability.
- Enables scalable adaptation of TUS parameters for diverse experimental designs and compound evaluation.
Translational & Preclinical Research
- Aligns neuromodulation protocols with human anatomical variability for translational biomarker development.
- Ensures continuity from simulation-based planning to in vivo human experimentation, reducing translational risk.
- Provides a validated workflow for advancing non-invasive CNS modulation technologies toward clinical readiness.
Pipeline & Workflow Integration
This protocol bridges early discovery, target validation, and preclinical neuromodulation research by integrating imaging, simulation, and neuronavigation tools.
- Discovery Biology: Supports hypothesis testing and pathway clarification through precise target and trajectory mapping.
- Screening: Delivers reproducible, quantitative acoustic and thermal simulation outputs for assay standardization.
- Analytics: Provides spatial registration accuracy and simulation-derived safety metrics for cross-condition comparison.
- Translational Research: Maintains continuity from in silico planning to human experimentation, supporting biomarker alignment.
- Enterprise Reuse: Establishes a modular, open-source workflow adaptable across CNS targets and experimental paradigms.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neuromodulation outcomes and reduces mechanistic ambiguity.
- Operational Value: Standardizes imaging, simulation, and targeting steps for reproducibility and scalability.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient advancement of CNS modulation programs.
- Portfolio Impact: Supports risk-adjusted prioritization of neuromodulation targets and experimental designs.
Implementation Considerations
- Requires expertise in neuroimaging, simulation software, and neuronavigation systems.
- Demands access to high-resolution MRI or CT imaging and computational infrastructure for simulations.
- Necessitates cross-team standardization of imaging, simulation, and targeting protocols.
- Adaptable to various transducer configurations and anatomical models with appropriate validation.
- Dependent on accurate registration and calibration to ensure targeting fidelity and safety compliance.
Biopharma FAQs
Why does null hypothesis testing matter for TUS parameter selection?
Null hypothesis testing ensures that observed neuromodulatory effects are statistically significant and not due to random variation, supporting robust target validation in TUS experiments.
How does independent variable isolation fit in acoustic and thermal simulation planning?
Isolating variables such as ultrasound frequency and trajectory during simulation enables precise attribution of observed effects, strengthening mechanistic confidence in neuromodulation outcomes.
What do quantitative dependent variable measurements enable in TUS experiments?
Quantitative measurements of acoustic fields, thermal profiles, and spatial registration provide objective criteria for comparing experimental conditions and optimizing neuromodulation protocols.
Why are replication requirements critical for cross-functional TUS studies?
Replication ensures that neuromodulation effects are reproducible across subjects and sessions, facilitating collaboration and data integration across discovery and translational teams.
What statistical analysis capabilities are required before implementing TUS protocols?
Robust statistical analysis is needed to validate simulation outputs, assess targeting accuracy, and confirm that safety and efficacy thresholds are met prior to experimental implementation.
